For the three serotypes tested, AAV9 yields increased ~7-fold, AAV2 yields increased ~15-fold, and AAV8 yields increased ~19-fold. AAV manufacturing amenable for preclinical and clinical applications. and Sf9 cells are grown in suspension in serum-free media and can reach higher…